NanoViricides, Inc. Press Releases

NNVC 
$4.12
*  
0.01
0.24%
Get NNVC Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading NNVC now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NanoViricides President Dr. Diwan was an Invited Participant at the Prestigious CEO Roundtable
7/23/2014 7:00:00 AM - Business Wire

NanoViricides Inc. Celebrated the Grand Opening of Its New R&D and cGMP Pilot Manufacturing Facility with Congressman Jim Himes as the Chief Guest Yesterday
7/22/2014 7:00:00 AM - Business Wire

NanoViricides President Dr. Diwan Presented FluCide Data at the 3rd Annual Influenza Conference held by GTC Bio on Friday, July 11
7/14/2014 8:00:00 AM - Business Wire

NanoViricides Reports that its Director Dr. Milton Boniuk, a Director, Has Invested $5M into the Company in a Convertible Debenture
7/2/2014 7:00:00 AM - Business Wire

NanoViricides Reports That a Certificate of Occupancy Has Been Issued for the New cGMP Manufacturing and R&D Facility in Shelton, CT
6/25/2014 7:00:00 AM - Business Wire

NanoViricides President Dr. Diwan to Present at the Wall Street Analyst Forum Today, June 19th, in New York City
6/19/2014 8:30:00 AM - Business Wire

NanoViricides, Inc. Reports That NNVC is in the Preliminary Additions List of The Russell Global, The Russell 3000, The Russell 2000 and the Russell Microcap Indexes
6/16/2014 7:00:00 AM - Business Wire

NanoViricides CEO Dr. Seymour to Present at the LD Micro Invitational Conference Today, June 4th
6/4/2014 7:00:00 AM - Business Wire

NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates
5/19/2014 7:00:00 AM - Business Wire

NanoViricides Reports Novel Drug Candidates for Treatment of the MERS (Middle East Respiratory Syndrome) Corona Virus Ready for Animal Testing
5/5/2014 7:00:00 AM - Business Wire